A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protoc
about
A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protoc
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A phase I followed by a random ...... atment (REVIVAL): study protoc
@en
A phase I followed by a random ...... cancer as first line treatment
@nl
type
label
A phase I followed by a random ...... atment (REVIVAL): study protoc
@en
A phase I followed by a random ...... cancer as first line treatment
@nl
prefLabel
A phase I followed by a random ...... atment (REVIVAL): study protoc
@en
A phase I followed by a random ...... cancer as first line treatment
@nl
P2093
P2860
P1433
P1476
A phase I followed by a random ...... a randomized controlled trial
@en
P2093
Gwen M H E Dackus
Harm van Tinteren
Jan H M Schellens
Philip C Schouten
Sabine C Linn
Serena Marchetti
P2860
P2888
P356
10.1186/S13063-016-1423-0
P50
P577
2016-06-21T00:00:00Z
P6179
1013860095